Krystal Biotech

KRYS stock is not Shariah-compliant

Zoya API tarafından desteklenmektedir

About Krystal Biotech (KRYS)

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in redosable gene therapy to treat serious rare diseases. Its lead product candidate beremagene geperpavec is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also developing other product candidates for conditions such as autosomal recessive congenital ichthyosis, wrinkles and aged skin, cystic fibrosis, and netherton syndrome.

Sıkça sorulan sorular

Is Krystal Biotech (KRYS) stock halal to invest in?
Yes, KRYS is not Shariah-compliant based on the company’s latest financial reports and therefore considered halal to invest in. Last updated on Aug 27, 2024.
No, KRYS is not Shariah-compliant based on the company’s latest financial reports and therefore not considered halal to invest in. Last updated on Aug 27, 2024.
KRYS is flagged as not Shariah-compliant in terms of Shariah compliance based on the company's latest financial reports. This means that while the company's operations do not definitively violate Islamic guidelines, there are certain aspects of Krystal Biotech's business that require careful consideration. Last updated on Aug 27, 2024.
Does Krystal Biotech have any interest income?
Yes, Krystal Biotech does have interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Krystal Biotech reported revenue of 50699000 and interest income of 22624000. The interest income represents 30.86% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
No, Krystal Biotech has not reported any interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Krystal Biotech reported total revenue of 50699000, with no separate interest income disclosed. However, it's worth noting that some companies may report interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Krystal Biotech stock is Shariah-compliant?
İslami Finansal Kurumlar için Muhasebe ve Denetim Organizasyonu tarafından belirlenen yönergeleri kullanıyoruz (AAOIFI) tarafından şeriata uygunluğu değerlendirmek üzere kurulmuştur. AAOIFI, Şeriat'a uygunluk değerlendirmesi yapan önde gelen uluslararası bir kuruluştur. İslami finans için standartlar. Kılavuz ilkeleri, bir şirketin ticari faaliyetlerinin ve finansal yapı İslami ilkelerle uyumludur. Bu standartlar, İslami finans sektöründe geniş çapta saygı görmektedir. ve hisse senetlerinin Şeriata uygunluğunu değerlendirmek için tutarlı bir çerçeve sağlar. diğer finansal araçlar. AAOIFI'nin Şeriat kurulunda Şeyh Muhammed gibi tanınmış akademisyenler yer almaktadır. Taqi Usmani, Şeyh AbdulSattar Abu Ghuddah ve Şeyh Abdullah AlManea.
How often is Krystal Biotech stock reviewed for Shariah compliance?
The Shariah compliance status of Krystal Biotech stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on Krystal Biotech's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of KRYS, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from Krystal Biotech stock considered halal?
Yes, dividends from KRYS are considered halal. However, you may need to purify a portion of the dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of impermissible revenue for Krystal Biotech (KRYS), check the Zoya app. For more details on the purification process, read our comprehensive guide.
No, dividends from KRYS are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my Krystal Biotech shares?
If you hold Krystal Biotech stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on stocks can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculation tool. For an even easier experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

How to buy Krystal Biotech (KRYS) stock on Zoya

  1. Ücretsiz bir Zoya hesabı için kaydolun
    Başlamak çok kolay. Doğrudan web sitemizden veya iOS veya Android için Zoya uygulamasını indirerek bir hesaba kaydolabilirsiniz.
  2. Bir aracı kurum hesabı bağlayın
    Zoya, Zoya üzerinden hisse senedi satın almanın ve yönetmenin sorunsuz bir yolu için Alpaca ve diğerleri gibi önde gelen aracı kurumlarla ortaklık yapmaktadır.
  3. Ne kadar yatırım yapacağınıza karar verin
    Arama ekranına gidin ve arama çubuğuna hisse senedinin adını yazın. Ardından, satın al düğmesine tıklayın ve dolar veya hisse sayısı cinsinden yatırım yapmak istediğiniz tutarı girin. Yatırımınızı onaylamadan önce gerçek zamanlı hisse senedi fiyatını ve tahmini hisse miktarını inceleyin.
  4. Portföyünüzü tek bir yerden yönetin
    Yeni satın aldığınız hisse senedini Zoya portföyünüzde diğer varlıklarınızla birlikte bulabilirsiniz. Portföyünüzün Şeriat uyumluluğundaki herhangi bir değişiklikten haberdar olmak için uyarıları etkinleştirin.

Topluluk gönderileri

İlgili stoklar

See how Krystal Biotech compares with its peers: